Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

NCT00496392 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
115
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nycomed